Clinical Trial Update: Tenelia Triple Combination Study [Phase 3]

View source ↗

Summary

A Phase 3 trial investigating the Tenelia triple combination for Type 2 Diabetes Mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Tenelia (teneligliptin)

Snippet

Sponsor: Handok Inc. | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED